Viral Vector Production (Research-use) Market Size, Share, Growth, and Industry Analysis, By Types (Adeno-associated virus (AAV),,Lentivirus,,Adenovirus,,Retrovirus), By Applications Covered (Cell & Gene Therapy Development, Vaccine Development, Biopharmaceutical and Pharmaceutical , Discovery, Biomedical Research), Regional Insights and Forecast to 2033

Detailed TOC of Global Viral Vector Production (Research-use) Market Insights, Forecast to 2033

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vector Production (Research-use) Market Size Growth Rate by Type, 2024 VS 2025 VS 2033
1.2.2 Adeno-associated virus (AAV)
1.2.3 Lentivirus
1.2.4 Adenovirus
1.2.5 Retrovirus
1.2.6 Others
1.3 Market by Application
1.3.1 Global Viral Vector Production (Research-use) Market Size Growth Rate by Application, 2024 VS 2025 VS 2033
1.3.2 Cell & Gene Therapy Development
1.3.3 Vaccine Development
1.3.4 Biopharmaceutical and Pharmaceutical Discovery
1.3.5 Biomedical Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Vector Production (Research-use) Market Perspective (2024-2033)
2.2 Global Viral Vector Production (Research-use) Growth Trends by Region
2.2.1 Viral Vector Production (Research-use) Market Size by Region: 2024 VS 2025 VS 2033
2.2.2 Viral Vector Production (Research-use) Historic Market Size by Region (2024-2023)
2.2.3 Viral Vector Production (Research-use) Forecasted Market Size by Region (2024-2033)
2.3 Viral Vector Production (Research-use) Market Dynamics
2.3.1 Viral Vector Production (Research-use) Industry Trends
2.3.2 Viral Vector Production (Research-use) Market Drivers
2.3.3 Viral Vector Production (Research-use) Market Challenges
2.3.4 Viral Vector Production (Research-use) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Viral Vector Production (Research-use) by Players
3.1.1 Global Viral Vector Production (Research-use) Revenue by Players (2024-2023)
3.1.2 Global Viral Vector Production (Research-use) Revenue Market Share by Players (2024-2023)
3.2 Global Viral Vector Production (Research-use) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Viral Vector Production (Research-use), Ranking by Revenue, 2021 VS 2025 VS 2023
3.4 Global Viral Vector Production (Research-use) Market Concentration Ratio
3.4.1 Global Viral Vector Production (Research-use) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vector Production (Research-use) Revenue in 2025
3.5 Global Key Players of Viral Vector Production (Research-use) Head office and Area Served
3.6 Global Key Players of Viral Vector Production (Research-use), Product and Application
3.7 Global Key Players of Viral Vector Production (Research-use), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vector Production (Research-use) Breakdown Data by Type
4.1 Global Viral Vector Production (Research-use) Historic Market Size by Type (2024-2023)
4.2 Global Viral Vector Production (Research-use) Forecasted Market Size by Type (2024-2033)
5 Viral Vector Production (Research-use) Breakdown Data by Application
5.1 Global Viral Vector Production (Research-use) Historic Market Size by Application (2024-2023)
5.2 Global Viral Vector Production (Research-use) Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Viral Vector Production (Research-use) Market Size (2024-2033)
6.2 North America Viral Vector Production (Research-use) Market Size by Type
6.2.1 North America Viral Vector Production (Research-use) Market Size by Type (2024-2023)
6.2.2 North America Viral Vector Production (Research-use) Market Size by Type (2024-2033)
6.2.3 North America Viral Vector Production (Research-use) Market Share by Type (2024-2033)
6.3 North America Viral Vector Production (Research-use) Market Size by Application
6.3.1 North America Viral Vector Production (Research-use) Market Size by Application (2024-2023)
6.3.2 North America Viral Vector Production (Research-use) Market Size by Application (2024-2033)
6.3.3 North America Viral Vector Production (Research-use) Market Share by Application (2024-2033)
6.4 North America Viral Vector Production (Research-use) Market Size by Country
6.4.1 North America Viral Vector Production (Research-use) Market Size by Country: 2024 VS 2025 VS 2033
6.4.2 North America Viral Vector Production (Research-use) Market Size by Country (2024-2023)
6.4.3 North America Viral Vector Production (Research-use) Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Viral Vector Production (Research-use) Market Size (2024-2033)
7.2 Europe Viral Vector Production (Research-use) Market Size by Type
7.2.1 Europe Viral Vector Production (Research-use) Market Size by Type (2024-2023)
7.2.2 Europe Viral Vector Production (Research-use) Market Size by Type (2024-2033)
7.2.3 Europe Viral Vector Production (Research-use) Market Share by Type (2024-2033)
7.3 Europe Viral Vector Production (Research-use) Market Size by Application
7.3.1 Europe Viral Vector Production (Research-use) Market Size by Application (2024-2023)
7.3.2 Europe Viral Vector Production (Research-use) Market Size by Application (2024-2033)
7.3.3 Europe Viral Vector Production (Research-use) Market Share by Application (2024-2033)
7.4 Europe Viral Vector Production (Research-use) Market Size by Country
7.4.1 Europe Viral Vector Production (Research-use) Market Size by Country: 2024 VS 2025 VS 2033
7.4.2 Europe Viral Vector Production (Research-use) Market Size by Country (2024-2023)
7.4.3 Europe Viral Vector Production (Research-use) Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Viral Vector Production (Research-use) Market Size (2024-2033)
8.2 China Viral Vector Production (Research-use) Market Size by Type
8.2.1 China Viral Vector Production (Research-use) Market Size by Type (2024-2023)
8.2.2 China Viral Vector Production (Research-use) Market Size by Type (2024-2033)
8.2.3 China Viral Vector Production (Research-use) Market Share by Type (2024-2033)
8.3 China Viral Vector Production (Research-use) Market Size by Application
8.3.1 China Viral Vector Production (Research-use) Market Size by Application (2024-2023)
8.3.2 China Viral Vector Production (Research-use) Market Size by Application (2024-2033)
8.3.3 China Viral Vector Production (Research-use) Market Share by Application (2024-2033)
9 Asia (excluding China)
9.1 Asia Viral Vector Production (Research-use) Market Size (2024-2033)
9.2 Asia Viral Vector Production (Research-use) Market Size by Type
9.2.1 Asia Viral Vector Production (Research-use) Market Size by Type (2024-2023)
9.2.2 Asia Viral Vector Production (Research-use) Market Size by Type (2024-2033)
9.2.3 Asia Viral Vector Production (Research-use) Market Share by Type (2024-2033)
9.3 Asia Viral Vector Production (Research-use) Market Size by Application
9.3.1 Asia Viral Vector Production (Research-use) Market Size by Application (2024-2023)
9.3.2 Asia Viral Vector Production (Research-use) Market Size by Application (2024-2033)
9.3.3 Asia Viral Vector Production (Research-use) Market Share by Application (2024-2033)
9.4 Asia Viral Vector Production (Research-use) Market Size by Region
9.4.1 Asia Viral Vector Production (Research-use) Market Size by Region: 2024 VS 2025 VS 2033
9.4.2 Asia Viral Vector Production (Research-use) Market Size by Region (2024-2023)
9.4.3 Asia Viral Vector Production (Research-use) Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Viral Vector Production (Research-use) Market Size (2024-2033)
10.2 Middle East, Africa, and Latin America Viral Vector Production (Research-use) Market Size by Type
10.2.1 Middle East, Africa, and Latin America Viral Vector Production (Research-use) Market Size by Type (2024-2023)
10.2.2 Middle East, Africa, and Latin America Viral Vector Production (Research-use) Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Viral Vector Production (Research-use) Market Share by Type (2024-2033)
10.3 Middle East, Africa, and Latin America Viral Vector Production (Research-use) Market Size by Application
10.3.1 Middle East, Africa, and Latin America Viral Vector Production (Research-use) Market Size by Application (2024-2023)
10.3.2 Middle East, Africa, and Latin America Viral Vector Production (Research-use) Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Viral Vector Production (Research-use) Market Share by Application (2024-2033)
10.4 Middle East, Africa, and Latin America Viral Vector Production (Research-use) Market Size by Country
10.4.1 Middle East, Africa, and Latin America Viral Vector Production (Research-use) Market Size by Country: 2024 VS 2025 VS 2033
10.4.2 Middle East, Africa, and Latin America Viral Vector Production (Research-use) Market Size by Country (2024-2023)
10.4.3 Middle East, Africa, and Latin America Viral Vector Production (Research-use) Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Viral Vector Production (Research-use) Introduction
11.1.4 Merck KGaA Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.1.5 Merck KGaA Recent Developments
11.2 Lonza
11.2.1 Lonza Company Details
11.2.2 Lonza Business Overview
11.2.3 Lonza Viral Vector Production (Research-use) Introduction
11.2.4 Lonza Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.2.5 Lonza Recent Developments
11.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
11.3.1 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Company Details
11.3.2 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Overview
11.3.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Viral Vector Production (Research-use) Introduction
11.3.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.3.5 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Developments
11.4 Cobra Biologics Ltd.
11.4.1 Cobra Biologics Ltd. Company Details
11.4.2 Cobra Biologics Ltd. Business Overview
11.4.3 Cobra Biologics Ltd. Viral Vector Production (Research-use) Introduction
11.4.4 Cobra Biologics Ltd. Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.4.5 Cobra Biologics Ltd. Recent Developments
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Viral Vector Production (Research-use) Introduction
11.5.4 Thermo Fisher Scientific Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.5.5 Thermo Fisher Scientific Recent Developments
11.6 Waisman Biomanufacturing
11.6.1 Waisman Biomanufacturing Company Details
11.6.2 Waisman Biomanufacturing Business Overview
11.6.3 Waisman Biomanufacturing Viral Vector Production (Research-use) Introduction
11.6.4 Waisman Biomanufacturing Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.6.5 Waisman Biomanufacturing Recent Developments
11.7 Genezen
11.7.1 Genezen Company Details
11.7.2 Genezen Business Overview
11.7.3 Genezen Viral Vector Production (Research-use) Introduction
11.7.4 Genezen Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.7.5 Genezen Recent Developments
11.8 YPOSKESI
11.8.1 YPOSKESI Company Details
11.8.2 YPOSKESI Business Overview
11.8.3 YPOSKESI Viral Vector Production (Research-use) Introduction
11.8.4 YPOSKESI Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.8.5 YPOSKESI Recent Developments
11.9 Advanced BioScience Laboratories, Inc. (ABL, Inc.)
11.9.1 Advanced BioScience Laboratories, Inc. (ABL, Inc.) Company Details
11.9.2 Advanced BioScience Laboratories, Inc. (ABL, Inc.) Business Overview
11.9.3 Advanced BioScience Laboratories, Inc. (ABL, Inc.) Viral Vector Production (Research-use) Introduction
11.9.4 Advanced BioScience Laboratories, Inc. (ABL, Inc.) Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.9.5 Advanced BioScience Laboratories, Inc. (ABL, Inc.) Recent Developments
11.10 Novasep Holding S.A.S
11.10.1 Novasep Holding S.A.S Company Details
11.10.2 Novasep Holding S.A.S Business Overview
11.10.3 Novasep Holding S.A.S Viral Vector Production (Research-use) Introduction
11.10.4 Novasep Holding S.A.S Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.10.5 Novasep Holding S.A.S Recent Developments
11.11 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.)
11.11.1 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Company Details
11.11.2 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Business Overview
11.11.3 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Viral Vector Production (Research-use) Introduction
11.11.4 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.11.5 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Recent Developments
11.12 Vigene Biosciences, Inc.
11.12.1 Vigene Biosciences, Inc. Company Details
11.12.2 Vigene Biosciences, Inc. Business Overview
11.12.3 Vigene Biosciences, Inc. Viral Vector Production (Research-use) Introduction
11.12.4 Vigene Biosciences, Inc. Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.12.5 Vigene Biosciences, Inc. Recent Developments
11.13 General Electric Company (GE Healthcare)
11.13.1 General Electric Company (GE Healthcare) Company Details
11.13.2 General Electric Company (GE Healthcare) Business Overview
11.13.3 General Electric Company (GE Healthcare) Viral Vector Production (Research-use) Introduction
11.13.4 General Electric Company (GE Healthcare) Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.13.5 General Electric Company (GE Healthcare) Recent Developments
11.14 CEVEC Pharmaceuticals GmbH
11.14.1 CEVEC Pharmaceuticals GmbH Company Details
11.14.2 CEVEC Pharmaceuticals GmbH Business Overview
11.14.3 CEVEC Pharmaceuticals GmbH Viral Vector Production (Research-use) Introduction
11.14.4 CEVEC Pharmaceuticals GmbH Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.14.5 CEVEC Pharmaceuticals GmbH Recent Developments
11.15 Batavia Biosciences B.V.
11.15.1 Batavia Biosciences B.V. Company Details
11.15.2 Batavia Biosciences B.V. Business Overview
11.15.3 Batavia Biosciences B.V. Viral Vector Production (Research-use) Introduction
11.15.4 Batavia Biosciences B.V. Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.15.5 Batavia Biosciences B.V. Recent Developments
11.16 Biovion oy
11.16.1 Biovion oy Company Details
11.16.2 Biovion oy Business Overview
11.16.3 Biovion oy Viral Vector Production (Research-use) Introduction
11.16.4 Biovion oy Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.16.5 Biovion oy Recent Developments
11.17 Wuxi AppTec Co., Ltd.
11.17.1 Wuxi AppTec Co., Ltd. Company Details
11.17.2 Wuxi AppTec Co., Ltd. Business Overview
11.17.3 Wuxi AppTec Co., Ltd. Viral Vector Production (Research-use) Introduction
11.17.4 Wuxi AppTec Co., Ltd. Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.17.5 Wuxi AppTec Co., Ltd. Recent Developments
11.18 VGXI, Inc.
11.18.1 VGXI, Inc. Company Details
11.18.2 VGXI, Inc. Business Overview
11.18.3 VGXI, Inc. Viral Vector Production (Research-use) Introduction
11.18.4 VGXI, Inc. Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.18.5 VGXI, Inc. Recent Developments
11.19 Catalent Inc.
11.19.1 Catalent Inc. Company Details
11.19.2 Catalent Inc. Business Overview
11.19.3 Catalent Inc. Viral Vector Production (Research-use) Introduction
11.19.4 Catalent Inc. Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.19.5 Catalent Inc. Recent Developments
11.20 Miltenyi Biotec GmbH
11.20.1 Miltenyi Biotec GmbH Company Details
11.20.2 Miltenyi Biotec GmbH Business Overview
11.20.3 Miltenyi Biotec GmbH Viral Vector Production (Research-use) Introduction
11.20.4 Miltenyi Biotec GmbH Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.20.5 Miltenyi Biotec GmbH Recent Developments
11.21 SIRION Biotech GmbH
11.21.1 SIRION Biotech GmbH Company Details
11.21.2 SIRION Biotech GmbH Business Overview
11.21.3 SIRION Biotech GmbH Viral Vector Production (Research-use) Introduction
11.21.4 SIRION Biotech GmbH Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.21.5 SIRION Biotech GmbH Recent Developments
11.22 Virovek Incorporation
11.22.1 Virovek Incorporation Company Details
11.22.2 Virovek Incorporation Business Overview
11.22.3 Virovek Incorporation Viral Vector Production (Research-use) Introduction
11.22.4 Virovek Incorporation Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.22.5 Virovek Incorporation Recent Developments
11.23 BioNTech IMFS GmbH
11.23.1 BioNTech IMFS GmbH Company Details
11.23.2 BioNTech IMFS GmbH Business Overview
11.23.3 BioNTech IMFS GmbH Viral Vector Production (Research-use) Introduction
11.23.4 BioNTech IMFS GmbH Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.23.5 BioNTech IMFS GmbH Recent Developments
11.24 VIVEbiotech S.L.
11.24.1 VIVEbiotech S.L. Company Details
11.24.2 VIVEbiotech S.L. Business Overview
11.24.3 VIVEbiotech S.L. Viral Vector Production (Research-use) Introduction
11.24.4 VIVEbiotech S.L. Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.24.5 VIVEbiotech S.L. Recent Developments
11.25 Creative Biogene
11.25.1 Creative Biogene Company Details
11.25.2 Creative Biogene Business Overview
11.25.3 Creative Biogene Viral Vector Production (Research-use) Introduction
11.25.4 Creative Biogene Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.25.5 Creative Biogene Recent Developments
11.26 Vibalogics GmbH
11.26.1 Vibalogics GmbH Company Details
11.26.2 Vibalogics GmbH Business Overview
11.26.3 Vibalogics GmbH Viral Vector Production (Research-use) Introduction
11.26.4 Vibalogics GmbH Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.26.5 Vibalogics GmbH Recent Developments
11.27 Takara Bio.
11.27.1 Takara Bio. Company Details
11.27.2 Takara Bio. Business Overview
11.27.3 Takara Bio. Viral Vector Production (Research-use) Introduction
11.27.4 Takara Bio. Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.27.5 Takara Bio. Recent Developments
11.28 Cell and Gene Therapy Catapult
11.28.1 Cell and Gene Therapy Catapult Company Details
11.28.2 Cell and Gene Therapy Catapult Business Overview
11.28.3 Cell and Gene Therapy Catapult Viral Vector Production (Research-use) Introduction
11.28.4 Cell and Gene Therapy Catapult Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.28.5 Cell and Gene Therapy Catapult Recent Developments
11.29 BlueBird Bio
11.29.1 BlueBird Bio Company Details
11.29.2 BlueBird Bio Business Overview
11.29.3 BlueBird Bio Viral Vector Production (Research-use) Introduction
11.29.4 BlueBird Bio Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.29.5 BlueBird Bio Recent Developments
11.30 Addgene, Inc.
11.30.1 Addgene, Inc. Company Details
11.30.2 Addgene, Inc. Business Overview
11.30.3 Addgene, Inc. Viral Vector Production (Research-use) Introduction
11.30.4 Addgene, Inc. Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.30.5 Addgene, Inc. Recent Developments
11.31 Aldevron, L.L.C.
11.31.1 Aldevron, L.L.C. Company Details
11.31.2 Aldevron, L.L.C. Business Overview
11.31.3 Aldevron, L.L.C. Viral Vector Production (Research-use) Introduction
11.31.4 Aldevron, L.L.C. Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.31.5 Aldevron, L.L.C. Recent Developments
11.32 Audentes Therapeutics
11.32.1 Audentes Therapeutics Company Details
11.32.2 Audentes Therapeutics Business Overview
11.32.3 Audentes Therapeutics Viral Vector Production (Research-use) Introduction
11.32.4 Audentes Therapeutics Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.32.5 Audentes Therapeutics Recent Developments
11.33 BioMarin Pharmaceutical
11.33.1 BioMarin Pharmaceutical Company Details
11.33.2 BioMarin Pharmaceutical Business Overview
11.33.3 BioMarin Pharmaceutical Viral Vector Production (Research-use) Introduction
11.33.4 BioMarin Pharmaceutical Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.33.5 BioMarin Pharmaceutical Recent Developments
11.34 RegenxBio, Inc.
11.34.1 RegenxBio, Inc. Company Details
11.34.2 RegenxBio, Inc. Business Overview
11.34.3 RegenxBio, Inc. Viral Vector Production (Research-use) Introduction
11.34.4 RegenxBio, Inc. Revenue in Viral Vector Production (Research-use) Business (2024-2023)
11.34.5 RegenxBio, Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details